patient_id,note_date,index_date,eligible_label,ineligible_reasons,age,sex,race_ethnicity,height_cm,weight_kg,bmi,smoking_status,alcohol_use,outpatient_visits_last_12m,diagnoses,medications,allergies,pregnancy_status,recent_cardiovascular_event_6m,systemic_steroids_chronic,active_malignancy_systemic_tx_12m,narrative_note
P0008,2025-10-22,2025-10-30,INELIGIBLE,eGFR below inclusion threshold (32 mL/min/1.73 m²),66,Female,Black or African American,159,88,34.8,Current,Moderate,3,Type 2 diabetes mellitus; Hypertension,Metformin ER 1000 mg BID; Atorvastatin 20 mg daily,Penicillin (rash),Not pregnant,No,No,No,66-year-old Female with a history of type 2 diabetes diagnosed 8 years ago. Seen for routine outpatient follow-up. Reports mild fatigue. Current therapy: Metformin ER 1000 mg BID; Atorvastatin 20 mg daily. Home glucose readings: fasting 120–160 mg/dL. Comorbidities: hypertension. Denies hypoglycemia requiring assistance. Last HbA1c on 2025-10-30 was 8.7%. Plan: optimize regimen and follow-up in 8–12 weeks. Not eligible for cohort due to: eGFR below inclusion threshold (32 mL/min/1.73 m²).
